Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin versus watchful waiting for acute otitis media in young children
IRCT20111224008507N2Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of amoxicillin and amoxicillin + clavulanate in acute otitis media (AOM) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Fever, Otalgia and 7 more. Started Aug 2017; status: completed.
02
Drugs
amoxicillinamoxicillin + clavulanate
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on IRCT20111224008507N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111224008507N2.